Leukemia, Mast-Cell
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD (NCT00186628) | Stanford University | 2005-06-01 |
| Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia (NCT00233454) | Jason Robert Gotlib | 2005-03-01 |
Track Leukemia, Mast-Cell automatically
Every clearance here is in the API, with alerts when new ones post.